TG Therapeutics, Inc.
TGTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001001316
In the last 90 days, TG Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 431 institutions reported holding it in 13F filings for Q2 2026, worth $6.10B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in TG Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 214
- +18 vs. Q4 2022
- Shares held
- 94.9M
- +1.52M (+1.6%) vs. Q4 2022
- Total value
- $1.43B
- +$317.0M (+28.6%) vs. Q4 2022
- New holders
- 54
- 61 more added
- Sold out
- 36
- 62 more reduced
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TGTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 431 | $6.10B |
| Q1 2026 | 365 | $3.50B |
| Q4 2025 | 352 | $3.07B |
| Q3 2025 | 354 | $3.58B |
| Q2 2025 | 356 | $3.65B |
| Q1 2025 | 376 | $3.90B |
| Q4 2024 | 331 | $2.92B |
| Q3 2024 | 308 | $2.38B |
| Q2 2024 | 259 | $1.66B |
| Q1 2024 | 241 | $1.38B |
| Q4 2023 | 236 | $1.55B |
| Q3 2023 | 236 | $756.4M |
| Q2 2023 | 244 | $2.19B |
| Q1 2023 | 214 | $1.43B |
| Q4 2022 | 198 | $1.11B |
| Q3 2022 | 183 | $594.6M |
| Q2 2022 | 175 | $452.6M |
| Q1 2022 | 181 | $960.0M |
| Q4 2021 | 194 | $1.90B |
| Q3 2021 | 223 | $3.21B |
| Q2 2021 | 237 | $3.73B |
| Q1 2021 | 240 | $4.77B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding TG Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 1,272,776 | $19.1M | 0.00% | +498,536+64.4% | Added |
| Susquehanna International Group, LLP | 1,278,248 | $19.2M | 0.03% | +91,980+7.8% | Added |
| Northern Trust Corp | 1,301,767 | $19.6M | 0.00% | +30,969+2.4% | Added |
| Two Sigma Investments, LP | 1,352,915 | $20.3M | 0.06% | +339,917+33.6% | Added |
| Millennium Management LLC | 2,626,573 | $39.5M | 0.05% | −3,566,599−57.6% | Reduced |
| Geode Capital Management, LLC | 2,679,800 | $40.3M | 0.01% | +93,527+3.6% | Added |
| Alkeon Capital Management LLC | 2,689,923 | $40.5M | 0.26% | −354,494−11.6% | Reduced |
| Wellington Management Group LLP | 3,328,351 | $50.1M | 0.01% | −105,099−3.1% | Reduced |
| Jefferies Financial Group Inc. | 5,100,110 | $76.7M | 1.62% | +5,100,110 | New |
| FMR LLC | 5,820,036 | $87.5M | 0.01% | −1,368,826−19.0% | Reduced |
| State Street Corp | 7,643,805 | $115.0M | 0.01% | −2,771,356−26.6% | Reduced |
| BlackRock Inc. | 8,849,700 | $133.1M | 0.00% | −284,247−3.1% | Reduced |
| Darwin Global Management, Ltd. | 10,451,241 | $157.2M | 42.99% | +10,451,241 | New |
| Vanguard Group Inc | 13,379,507 | $201.2M | 0.01% | −2,123,257−13.7% | Reduced |
| Maverick Capital LtdSuperinvestorMaverick Capital | 0 | $0 | 0.00% | −4,318,700−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −2,562,100−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −504,829−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −386,467−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −288,462−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −215,527−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Capula Management Ltd | 0 | $0 | 0.00% | −134,060−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −133,600−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −126,383−100.0% | Sold out |
| EAM Global Investors LLC | 0 | $0 | 0.00% | −108,820−100.0% | Sold out |
| Moody Aldrich Partners LLC | 0 | $0 | 0.00% | −103,925−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −99,100−100.0% | Sold out |
| Capital Fund Management S.A. | 0 | $0 | 0.00% | −52,470−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −44,861−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −44,279−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −37,127−100.0% | Sold out |
| Kula Investments, LLC | 0 | $0 | 0.00% | −28,890−100.0% | Sold out |
| Sassicaia Capital Advisers LLC | 0 | $0 | 0.00% | −23,000−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −22,610−100.0% | Sold out |
| DuPont Capital Management Corp | 0 | $0 | 0.00% | −18,889−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −18,200−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −18,049−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −17,695−100.0% | Sold out |
| Glenmede Trust Co NA | 0 | $0 | 0.00% | −15,562−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −11,009−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −11,578−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −10,733−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| WJ Interests, LLC | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| RFP Financial Group LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Accurate Wealth Management, LLC | 0 | $0 | 0.00% | −680−100.0% | Sold out |
| Retirement Group, LLC | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −124−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −95−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Trustcore Financial Services, LLC | – | – | – | – | Not filed |
| Boulder Wealth Advisors, LLC | – | – | – | – | Not filed |